Global Vaccine Adjuvants Market 2022


Description

The global vaccine adjuvants market is set to increase by US$ 892.6 million from 2022 to 2028, representing a compound annual growth rate (CAGR) of 9.2% during the forecast period.

The report provides up-to-date market size data for period 2018-2021 and forecast to 2028 covering key market aspects like sales value for vaccine adjuvants. The global vaccine adjuvants market is segmented on the basis of product, disease, application, and region. On the basis of product, the global vaccine adjuvants market has been segmented into adjuvant emulsions, bacteria-derived adjuvants, carbohydrate adjuvants, liposome adjuvants, mineral salt-based adjuvant, tensoactive adjuvants, virus-like particles (VLP), others. The mineral salt-based adjuvant segment held the largest revenue share in 2021. By disease, the global vaccine adjuvants market has been segmented into cancer, infectious diseases, others. Among these, the infectious diseases segment was accounted for the highest revenue generator in 2021. Based on application, the global vaccine adjuvants market is categorized into commercial, research. In terms of geography, the global vaccine adjuvants market has been segmented into Asia Pacific, Europe, North America, Rest of the World (RoW).

The global vaccine adjuvants market is highly competitive. Top players covered in Global Vaccine Adjuvants Market Study are Agenus Inc., Associated British Foods plc (SPI Pharma Inc.), Avanti Polar Lipids Inc., Croda International plc (Brenntag Biosector A/S), CSL Limited, Dynavax Technologies Corporation, GSK plc, InvivoGen Corp., Merck & Co. Inc., MVP Laboratories Inc. (Phibro Animal Health Corporation), Novavax Inc., OZ Biosciences SAS, Seppic SA (Air Liquide S.A.). Competitive landscape gives a description of the competitive nature of the global vaccine adjuvants market and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

The report is an invaluable resource for companies and organizations active in this industry. It provides a cohesive picture of the vaccine adjuvants market to help drive informed decision making for industry executives, policy makers, academic, and analysts.


Report Scope

Product: adjuvant emulsions, bacteria-derived adjuvants, carbohydrate adjuvants, liposome adjuvants, mineral salt-based adjuvant, tensoactive adjuvants, virus-like particles (VLP), others
Disease: cancer, infectious diseases, others
Application: commercial, research
Region: Asia Pacific, Europe, North America, Rest of the World (RoW)
Years considered: this report covers the period 2018 to 2028
Company mentioned: Agenus Inc., Associated British Foods plc (SPI Pharma Inc.), Avanti Polar Lipids Inc., Croda International plc (Brenntag Biosector A/S), CSL Limited, Dynavax Technologies Corporation, GSK plc, InvivoGen Corp., Merck & Co. Inc., MVP Laboratories Inc. (Phibro Animal Health Corporation), Novavax Inc., OZ Biosciences SAS, Seppic SA (Air Liquide S.A.)


Key Benefits for Stakeholders

– Get a comprehensive picture of the global vaccine adjuvants market
– Pinpoint growth sectors and trends for investment


Table of Contents

Part 1. Introduction
– Scope of the study
– Study period
– Geographical scope
– Research methodology
Part 2. Vaccine adjuvants market overview
Part 3. Market breakdown by product
– Adjuvant emulsions
– Bacteria-derived adjuvants
– Carbohydrate adjuvants
– Liposome adjuvants
– Mineral salt-based adjuvant
– Tensoactive adjuvants
– Virus-like particles (VLP)
– Others
Part 4. Market breakdown by disease
– Cancer
– Infectious diseases
– Others
Part 5. Market breakdown by application
– Commercial
– Research
Part 6. Market breakdown by region
– Asia Pacific
– Europe
– North America
– Rest of the World (RoW)
Part 7. Key companies
– Agenus, Inc.
– Associated British Foods plc (SPI Pharma, Inc.)
– Avanti Polar Lipids, Inc.
– Croda International plc (Brenntag Biosector A/S)
– CSL Limited
– Dynavax Technologies Corporation
– GSK plc
– InvivoGen Corp.
– Merck & Co., Inc.
– MVP Laboratories Inc. (Phibro Animal Health Corporation)
– Novavax, Inc.
– OZ Biosciences SAS
– Seppic SA (Air Liquide S.A.)
About StrategyHelix
Disclaimer


USD 600

Want to customize this report? Our industry specialist will collaborate with you to deliver tailored data within a limited timeframe.
Scroll to Top

Request Free Sample Report

Global Vaccine Adjuvants Market 2022

Please fill out our form and we will get back to you.

CUSTOM RESEARCH

Global Vaccine Adjuvants Market 2022

Please fill out our form and we will get back to you.

login